Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics

Immunotherapy has emerged as one of the most promising approaches for ovarian cancer treatment. The tumor microenvironment (TME) is a key factor to consider when stimulating antitumoral responses as it consists largely of tumor promoting immunosuppressive cell types that attenuate antitumor immunity...

Full description

Bibliographic Details
Main Authors: Curtis W. McCloskey, Galaxia M. Rodriguez, Kristianne J. C. Galpin, Barbara C. Vanderhyden
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:Cancers
Subjects:
ovarian cancer
tumor microenvironment
immune infiltrating cells
chemotherapy
immunotherapy
syngeneic
transgenic models
hot vs. cold tumors
immunosuppression
Online Access:http://www.mdpi.com/2072-6694/10/8/244

Internet

http://www.mdpi.com/2072-6694/10/8/244

Similar Items